Literature DB >> 14763508

A simple and cost-effective method for the isolation of islets from nonhuman primates.

John J O'Neil1, Vaja Tchipashvili, Richard J Parent, Obinna Ugochukwu, Gaurav Chandra, Maria Koulmanda, Dicken Ko, Tatsuo Kawai.   

Abstract

Recent advances in islet cell transplantation have led to insulin independence in a majority of islet transplant recipients. However, there exists a need to overcome the shortage of donor tissue and the necessity for life-long immunosuppression. Preclinical studies in large animal models are necessary to evaluate the safety and efficacy of alternative approaches for clinical islet transplantation. The nonhuman primate serves as an appropriate animal model for such investigations; however, a major impediment in performing such preclinical research has been the difficulty in isolating islets of sufficient quantity and quality. The current study describes a simple and cost-effective method to isolate nonhuman primate islets to support preclinical islet transplantation research. The results of islet isolations from 54 cynomolgus monkeys and 4 baboons are reported. The pancreas was infused with Liberase HI and subjected to static digestion. The digested tissue was shaken, filtered through a mesh screen, applied to a discontinuous gradient, and centrifuged in much the same manner as with conventional rodent islet isolations. Islets were collected from the two interfaces, washed, and transplanted. Following purification, cynomolgus monkey islet isolation yields were 50,100 +/- 3120 IE total or 8760 +/- 420 IE/g pancreas with the percent purity and viability of 90.8 +/- 0.9 and 90.7 +/- 0.7, respectively. Total insulin content of the isolated islets was 405 +/- 53 microg insulin with DNA content being and 976 +/- 117 microg DNA, corresponding to a ratio of 0.57 microg insulin/microg DNA. STZ-induced diabetes was reversed in both mouse and nonhuman primate recipients, which possessed significant levels of c-peptide following transplantation and well-granulated islet grafts. The technique yields sufficient numbers of pure and viable islets to support preclinical research to develop improved strategies to prevent the immune destruction of the transplanted islet graft.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14763508     DOI: 10.3727/000000003771000110

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  9 in total

1.  Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?

Authors:  M Koulmanda; R N Smith; A Qipo; G Weir; H Auchincloss; T B Strom
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

2.  An optimized protocol for purification of functional islets of Langerhans.

Authors:  Youakim Saliba; Jules-Joel Bakhos; Tarek Itani; Nassim Farès
Journal:  Lab Invest       Date:  2016-11-28       Impact factor: 5.662

3.  Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term triple therapy.

Authors:  M Koulmanda; A Qipo; Z Fan; N Smith; H Auchincloss; X X Zheng; T B Strom
Journal:  Am J Transplant       Date:  2012-03-05       Impact factor: 8.086

4.  Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.

Authors:  Tetsu Oura; Dicken S C Ko; Svjetlan Boskovic; John J O'Neil; Vaja Chipashvili; Maria Koulmanda; Kiyohiko Hotta; Kento Kawai; Ognjenka Nadazdin; R Neal Smith; A B Cosimi; Tatsuo Kawai
Journal:  Cell Transplant       Date:  2015-09-02       Impact factor: 4.064

5.  Pancreatic islet isolation variables in non-human primates (rhesus macaques).

Authors:  P Andrades; C K Asiedu; B Gansuvd; S Inusah; K J Goodwin; L A Deckard; U Jargal; J M Thomas
Journal:  Diabetologia       Date:  2008-05-09       Impact factor: 10.122

6.  Human pancreatic islets and diabetes research.

Authors:  John S Kaddis; Barbara J Olack; Janice Sowinski; James Cravens; Juan L Contreras; Joyce C Niland
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

7.  Prevention of nonimmunologic loss of transplanted islets in monkeys.

Authors:  M Koulmanda; R S Sampathkumar; M Bhasin; A Qipo; Z Fan; G Singh; B Movahedi; M Duggan; V Chipashvili; T B Strom
Journal:  Am J Transplant       Date:  2014-06-09       Impact factor: 8.086

8.  Optimal allogeneic islet dose for transplantation in insulin-dependent diabetic Macaca fascicularis monkeys.

Authors:  Geun Soo Kim; Chan Woo Cho; Jong Hyun Lee; Du Yeon Shin; Han Sin Lee; Kyo Won Lee; Yeongbeen Kwon; Jae Sung Kim; Heung-Mo Yang; Sung Joo Kim; Jae Berm Park
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

9.  Protection of Pancreatic Islets Using Theranostic Silencing Nanoparticles in a Baboon Model of Islet Transplantation.

Authors:  Thomas Pomposelli; Ping Wang; Kazuhiro Takeuchi; Katsunori Miyake; Yuichi Ariyoshi; Hironosuke Watanabe; Xiaojuan Chen; Akira Shimizu; Neil Robertson; Kazuhiko Yamada; Anna Moore
Journal:  Diabetes       Date:  2020-08-27       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.